doi: 10.1152/ajpheart.00034.2016 163 MiyakeH.KoikeY.SeoS.LeeC.LiB.GanjiN.et al
S.SharifiF.JalilianE.et al (2018)
The glutamate aspartate transporter (GLAST) mediates L-glutamate-stimulated ascorbate-release via swelling-activated anion channels in cultured neonatal rodent astrocytes
Review: Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes A new review article published in the journal Acta Pharmaceutica Sinica B summarizes advancements in drug delivery systems for three main glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are recommended for selected patients with obesity or type 2 diabetes, depending on indication, comorbidities, and treatment goals
12 Patients received once-daily subcutaneous injections of liraglutide 3.0 mg or placebo, as well as counseling on lifestyle modification: at least 150 minutes of physical activity per week, a 500 kcal/day deficit diet, and macronutrient distribution of 30% energy from fat, 20% from protein, and 50% from carbohydrates
GPx1 The GPx1 gene, which encodes the first identified selenoprotein, is located on chromosome 3p21 [72, 73]